Cell Surface Markers Identify Astrocyte Subpopulations in the Adult Hippocampus With a Heterogeneous Response to Aging Lucía Casares‐Crespo, Marife Cano‐Jaimez, Raquel Anta, Alba Ripollés‐Boix, Fabián Robledo‐Yagüe, Sheila Zúñiga‐Trejos, Helena Mira Abstract Astrocyte diversity is currently expanding both between and within specific brain regions. Here, we assessed the spatial distribution and transcriptomic profile of two hippocampal astrocyte subpopulations, defined by combinatorial expression of the cell surface astrocyte markers ACSA‐1 or GLAST/SLC1A3, and ACSA‐2 or ATP1B2. Fluorescence activated cell sorting and genome‐wide transcriptomics by bulk RNAseq uncovered distinct transcriptional signatures of the two astrocyte subsets and highlighted heterogeneous responses during aging. The most abundant ATP1B2/GLAST double‐positive astrocytes corresponded to functionally specialized glial cells with increased protein glycosylation and stable gene expression patterns. Signatures related to mitochondrial respiration and cholesterol metabolism were induced during aging in ATP1B2 single‐positive astrocytes, while cell adhesion genes from the γ‐protocadherin cluster were repressed in double‐positive astrocytes. Heterochronic co‐culture assays with primary neurons show the loss of synaptogenic function of old ATP1B2/GLAST astrocytes. Our results complement previous studies demonstrating the presence of morphological and molecular astrocyte heterogeneity within the hippocampus, and uncover differences among astrocyte subsets in their transcriptomic response to aging. ATP1B2 and GLAST identify two astrocyte subpopulations in the hippocampus with distinct molecular signatures.Transcriptomic shifts during aging differ between both subpopulations.Aged ATP1B2+ astrocytes rewire their metabolism while double‐positive aged astrocytes display a reduced synaptogenic capability. [GLIA-74-0-g004.webp] Introduction Astrocytes play many essential roles in brain homeostasis. They provide trophic and metabolic support to neurons, regulate ionic balance, actively modulate synapses, participate in myelination and contribute to the blood–brain barrier. Recent studies reveal unexpected high levels of astrocyte heterogeneity, challenging the historical view of astrocytes as a uniform cell population. Boosted by the advent of single‐cell RNA sequencing (sc‐RNAseq) and spatial transcriptomics, astrocyte diversity continues to emerge both between and within specific brain areas (Chai et al. ; Morel et al. ; Boisvert et al. ; Lanjakornsiripan et al. ; Batiuk et al. ; Bayraktar et al. ; Borggrewe et al. ; Kantzer et al. ; Karpf et al. ; Su et al. ; de Ceglia et al. ; Viana et al. ; Zhou et al. ; Bocchi et al. ). To what extent astrocytes clustered according to their individual transcriptome are actually specialized cell subtypes with a distinct function and developmental trajectory is currently unknown (Hennes et al. ; Williamson et al. ). Exciting studies are shedding light on the origin of astrocyte diversity (Hochstim et al. ; Tsai et al. ; Molofsky et al. ; Liu et al. ; Clavreul et al. ; Markey et al. ; Xie et al. ; Zhou et al. ); however, most transcriptomic data still lack developmental perspective, functional validation, or both. Thus, additional efforts are needed to support astrocyte subtype classifications and to uncover how astrocyte diversity translates into functional specialization. Astrocyte cell membrane proteins have been instrumental in the identification and isolation of central nervous system glial subpopulations (Lin et al. ; Morel et al. ; Borggrewe et al. ; Kantzer et al. ). In a function‐based approach, differential expression of glutamate transporter‐1 (GLT‐1), involved in clearing excess glutamate from the synapse, allowed to uncover transcriptionally distinct cortical astrocytes with different electrophysiological properties (Morel et al. ). Expression of glutamate–aspartate transporter (GLAST) and another cell membrane protein, the astrocyte marker ATPase, Na+/K+ transporting, beta 2 polypeptide ATP1B2, also distinguished astrocyte subpopulations with specific transcriptional profiles in the forebrain, spinal cord, hindbrain and cerebellum (Borggrewe et al. ; Kantzer et al. ). An extracellular ATP1B2 epitope is recognized by the widely employed astrocyte cell surface antigen‐2 (ACSA‐2) (Kantzer et al. ), allowing for the isolation of astrocytes from freshly dissected tissue. One report showed that hindbrain and spinal cord GLAST‐positive and GLAST‐negative ATP1B2/ACSA‐2‐positive astrocytes respond differently to neuroinflammatory insults (Borggrewe et al. ), linking classifications based on the astrocyte cell surface proteome to gene expression profiles and functional responses. Age‐related astrocyte changes stemming from GLAST and ATP1B2 cell classifications have not been addressed so far. During aging, astrocytes undergo transcriptomic alterations that reveal a decline in their normal physiological functions (Boisvert et al. ; Clarke et al. ; Pan et al. ). These changes might contribute to cognitive impairment and vulnerability to neurodegenerative diseases (Labarta‐Bajo and Allen ). The hippocampus is one of the brain regions most susceptible to age‐related degeneration (Bettio et al. ; Hernández‐Frausto and Vivar ), but astrocyte heterogeneity and astrocyte functional changes during normal aging in the hippocampal formation remain underexplored (Clarke et al. ; Habib et al. ; Wu et al. ). To better understand astrocyte diversity and alterations in the young and old hippocampus, in this study we characterized ATP1B2 and GLAST expression at the mRNA and protein level in different hippocampal subfields during aging. We FACS‐isolated two astrocyte subpopulations on the basis of ATP1B2/ACSA‐2 and GLAST/ACSA‐1 cell surface protein expression and analyzed their transcriptome by bulk RNAseq. The results uncover subpopulation‐specific transcriptomic signatures and a differential impact of aging on the gene expression landscape of the astrocyte subpopulations. Repression of structural synapse formation genes in ATP1B2 and GLAST double‐positive astrocytes suggests a negative impact on excitatory synaptogenesis. This age‐related loss of function was confirmed in heterochronic hippocampal astrocyte‐neuron co‐culture assays. Methods Animals All experimental procedures were approved by the Institutional Animal Care and Use Committee of Instituto de Biomedicina de Valencia and by the Bioethical Committee of CSIC and CIPF (protocol 2023‐VSC‐PEA‐0212 and 2024/VSC/PEA/0094). Mice were maintained in the animal facility on a 12 h/12 h light/dark cycle under constant temperature (23°C) with food and water provided ad libitum. Wild‐type C57BL/6JRccHsd mice were purchased from Inotiv (https://www.inotivco.com/model/c57bl‐6jrcchsd) and wild‐type RjOrl:SWISS mice from Janvier Labs (https://janvier‐labs.com/en/fiche_produit/swiss_mouse/). Male C57Bl6/JRccHsd mice from in‐house breeding were used throughout unless otherwise stated. Data for RNAseq analysis was collected from astrocytes isolated from 2 and 18‐month‐old mice by FACS (in quadruplicate and triplicate, respectively). Mice aged 2, 18, and 24 months‐old were used for MACS and ISH (in situ hybridization) experiments (three replicates of each age). For immunohistochemistry assays, wild‐type RjOrl:SWISS male mice aged 2 and 18 months‐old were used (three replicates of each age). Neurons were isolated by MACS from embryonic day 18 (E18) RjOrl:SWISS mice. Finally, for lectin flow cytometry, 5 months‐old RjOrl:SWISS male mice were used. Astrocyte Isolation for FACS Cervical dislocation was used as a euthanasia method in FACS procedures. Brains were removed and hippocampi were dissected in cold Hank's balanced salt solution (HBSS, Sigma‐Aldrich, 55021C), under a binocular microscope. The myelin present in hippocampi was discarded in order to clean them as much as possible before the dissociation step. Hippocampal cell suspension was obtained using the Neural Tissue Dissociation Kit (Trypsin, Miltenyi, 130‐093‐231) in combination with the gentleMACS Octo Dissociator (Miltenyi, 130‐095‐937). The resulting suspension was then filtered through a 70 μm MACSSmartStrainers (Miltenyi, 130‐098‐462) with HBSS buffer with Ca2+ and Mg2+ (HBSS, Sigma‐Aldrich, 55037C) to remove any remaining clumps. Following the removal of myelin and red blood cells, the resulting cell pellet was resuspended in 100 μL of phosphate‐buffered saline (PBS) (without Ca2+/Mg2+) containing 0.5% bovine serum albumin (BSA) (Sigma‐Aldrich) and processed immediately for FACS. All steps were performed at 4°C. To prevent unspecific antibody binding, cells were incubated with FcR Blocking Reagent mouse (Miltenyi, 130‐092‐575) for 10 min before antibody labeling. Single cell hippocampal cell‐suspensions were then co‐stained with ACSA‐2‐FITC (Miltenyi Biotec, 130‐116‐243) (1:50 dilution) and ACSA‐1 (GLAST)‐PE (Miltenyi Biotec, 130‐118‐483) (1:50 dilution) and incubated for 1 h on ice in the dark. Next, cells were washed and collected in a new tube with PBS supplemented with 0.5% BSA. Cell debris and dead cells were excluded by 4′,6‐diamidino‐2‐phenylindole (DAPI) staining (1:1000 dilution). FACS was performed on a BD FACSAria III Cell Sorter using a 100 μm nozzle. Compensations were done on single‐color controls and gates were set on unstained samples. For the gating, we used side scatter versus forward scatter to select the population and forward scatter to exclude doublets (Figure ). Viable astrocytes (DAPI−) were selected and two distinct astrocyte subpopulations were sorted: ACSA‐2+ (A+) and ACSA‐1+/ACSA‐2+ (A+/G+) cells. Afterwards, cells were spun down at 300 g for 5 min at 4°C. In sorted astrocytes used for RNAseq, supernatant was removed and 5 μL of Cell Lysis Buffer from NEBNext Low Input RNA Library Prep Kit for Illumina (New England Biolabs, NEB #E6420S/L) was added. Finally, cells were flashed‐frozen and immediately store at −80°C until library preparation. In sorted astrocytes used for immunocytochemistry, supernatant was removed and cells were resuspended in pre‐warmed AstroMACS Medium (130‐117‐031) and seeded in 24‐well poly‐L‐lysine‐laminin‐coated dishes. Twenty‐four hours later, cells were fixed with 4% PFA during 10 min. Flow cytometry data was analyzed using FlowJo Software (v10.1). Lectin Flow Cytometry Hippocampal cells from young RjOrl:SWISS mice were dissociated as explained previously and labeled with lectins (1:400 FITC‐conjugated L‐PHA) (Vector Labs), GLAST‐PE (1:100), and ACSA‐2‐APC (1:100) in 0.5% BSA during 30 min on ice and protected from light. After washing 3 times with 1× PBS, cells were re‐suspended in PBS containing DAPI, which was used to exclude non‐viable cells for analysis. Cells were assessed for fluorescence in a FACS MACSQuantX (Miltenyi). For each sample, a total of 10,000 cells was analyzed. Mean fluorescence intensity (MFI) of lectins was quantified for A+/G+ and A+ cells of each mice. RNA Isolation and RNA Sequencing The RNAseq experiment was conducted by the Multigenic Analysis Unit from the UCIM‐INCLIVA (University of Valencia, Valencia, Spain). RNAseq libraries were made from total RNA isolated from sorted cells using NEBNext Low Input RNA Library Prep Kit for Illumina (New England Biolabs, NEB #E6420S/L) following manufacturer's instructions. Briefly, we started the procedure directly from cells; the sample that had the least was 84 cells and the one that had the most was 6193 cells. For the cDNA amplification, the number of cycles was adjusted to the input. cDNA was quantified using a Bioanalyzer High Sensitivity DNA Analysis (Agilent). Sequencing libraries were manually generated and adaptor's enrichment and ligation was performed. Then, quality and quantity of libraries was assessed again with High Sensitivity DNA Analysis Chip (Agilent). Libraries were then sequenced on the Illumina NextSeq 550 platform to generate 2 × 75 bp paired end reads using the Illumina NSQ 500/550 Hi Output KT v2.5 (150 CYS) (Illumina, San Diego, CA), according to the manufacturer's protocol. Libraries were sequenced on average to a depth of 14 M reads per library. Analysis of RNA Sequencing Data Bioinformatics analysis was conducted by the Bioinformatics Unit at INCLIVA. Sequence quality control was performed with FastQC v0.11.8 (Andrews ). Low‐quality bases and reads, as well as possible adapters, were removed with fastp v0.20.1 (Chen et al. ). Read mapping and expression quantification per isoform were performed using the STAR alignment (Dobin et al. ) and RSEM (Li and Dewey ), with the default parameters and the reference genome GRCm39. Data were loaded into R using the tximport package (Soneson et al. ). Prior to the exploratory analysis and differential expression study, all those genes with less than 2TPM in fewer than 3 samples were removed. To assess the quality of the samples an exploratory analysis was performed on the normalized counts that were obtained with the VST function of DESeq2 v.1.38.2 (Love et al. ) applying the option *blind = FALSE*. The differential expression study was performed with the DESeq2 package. A Benjamini‐Hochberg adjusted p value cutoff of 0.05 was set to select differentially expressed genes. Box and bar plots were generated with ggplot2 (Wickham ). The volcano plots were generated with EnhancedVolcano v1.16.0 (Blighe et al. ). Clustering heatmaps were prepared with the pheatmap package (Kolde ). Functional enrichment was performed using Enrichr search engine (https://maayanlab.cloud/Enrichr/) (Xie et al. ). A circular plot was created with functional enriched terms with the circlize package v0.4.16. To estimate astrocyte‐related pathway activity at the sample level, ssGSEA was applied to the VST‐normalized expression matrix using the GSVA (v2.0.7) package in R (v4.4). A predefined astrocyte gene signature (Endo et al. ) was used as input for enrichment scoring. ssGSEA enrichment scores were stratified by experimental group and displayed graphically using boxplots with the ggplot2 (v3.5.2) R package. In addition, Spearman's rank correlation coefficient was calculated with the cor.test function (stats package v4.4.1) to assess the relationship between the expression of the 825‐gene signature in the HIP group and each sample in our cohort. The expression of astrocyte‐related genes was visualized using a heatmap based on the VST‐normalized expression data with ComplexHeatmap R package (v2.22.0). Only the most representative genes reported in the publication from which the 825‐gene signature was derived, were shown. To perform the comparative analysis of astrocyte transcriptomic profiles between 20‐month (WT_M206_19.6m) and 5‐month (WT_M721_4.7m) samples (Habib et al. ), publicly available single‐cell RNA‐seq data (GSE143758) were used. The count matrix was imported from the Astrocytes raw counts file (GSE143758_Admouse_Hippocampus_3TimeCourses_Astrocytes_WT_AD_Aging.csv.gz) and subset to retain only columns corresponding to the samples of interest (M206 and M721). To obtain a pseudo‐bulk representation for each condition, raw counts were aggregated by summing gene expression values across all cells belonging to each condition. The aggregated count matrix was then processed using the edgeR package. We obtained log‐transformed counts per million (log‐CPM) values using the edgeR package. Finally, we assessed the global similarity between the two conditions by computing the Spearman rank correlation coefficient of M206 and M721 across all genes. Astrocyte Isolation for MACS Cervical dislocation was used as a euthanasia method in MACS procedures. Brains were removed and hippocampi were dissected in cold D‐PBS (GIBCO, 14287080), under a binocular microscope. The myelin present in hippocampi was discarded in order to clean the tissue as much as possible before the dissociation step. Hippocampal cell suspension was obtained using the Adult Brain Dissociation Kit (Miltenyi, 130‐107‐677) in combination with the gentleMACS Octo Dissociator (Miltenyi, 130‐095‐937). The resulting suspension was then filtered through a 70 μm MACSSmartStrainers (Miltenyi, 130‐098‐462) with D‐PBS to remove any remaining clumps. Following myelin and red blood cells removal, the resulting cell pellet was resuspended in 100 μL of phosphate‐buffered saline (PBS) (without Ca2+/Mg2+) containing 0.5% bovine serum albumin (BSA) (Sigma‐Aldrich) and processed immediately. Astrocytes (ACSA‐2+ cells) were positively selected using the Anti‐ACSA‐2 MicroBead Kit (Miltenyi, 130‐097‐678) following the manufacturer's procedure. Briefly, cells were incubated with 10 μL of FcR Blocking Reagent for 10 min at 4°C, followed by incubation with 10 μL of ACSA‐2 MicroBeads for 15 min at 4°C. Cells were then washed with 1 mL 0.5% BSA in PBS buffer and centrifuged at 300 × g for 5 min to remove excess beads from the solution. The pellet was resuspended with 500 μL of PBS 0.5% BSA and loaded onto an MS Column (Miltenyi), which was placed in the magnetic field of a MiniMACS Separator (Miltenyi). The magnetically labeled ACSA‐2‐positive cells were retained within the column and eluted as the positively selected cell fraction after removing the column from the magnet. After centrifugation, ACSA‐2+ cells were resuspended with pre‐warmed AstroMACS Medium (130‐117‐031) and seeded in 24‐well laminin‐coated dishes (80,000–100,000 astrocytes/well). Cell culture was maintained by replacing 50% of AstroMACS Medium every other day. After 14 days in culture, cells were fixed with 4% PFA for 10 min. Neuron Isolation for MACS E18 RjOrl:SWISS mice were decapitated. Brains were removed and hippocampi were dissected in cold D‐PBS (GIBCO, 14287080), under a binocular microscope. Hippocampal cell suspension was obtained using the Neural Tissue Dissociation Kit (Miltenyi, 130‐092‐628) in combination with the gentleMACS Octo Dissociator (Miltenyi, 130‐095‐937). The resulting suspension was then filtered through a 70 μm MACSSmartStrainers (Miltenyi, 130‐098‐462) with D‐PBS to remove any remaining clumps. Neurons and non‐neurons were selected using the Neuron Isolation Kit (Miltenyi, 130‐115‐389) following the manufacturer's procedure. Briefly, cells were incubated with 20 μL of Non‐Neuronal Cell Biotin‐Antibody Cocktail for 5 min at 4°C. Cells were then washed with 1 mL 0.5% BSA in PBS buffer and centrifuged at 300 × g for 5 min. The pellet was resuspended with 80 μL of PBS 0.5% BSA and cells were incubated with 20 μL of Anti‐Biotin MicroBeads for 10 min at 4°C. Then, the volume was adjusted to 500 μL and loaded onto a LS Column (Miltenyi), which was placed in the magnetic field of a MidiMACS Separator (Miltenyi). The magnetically labeled non‐neuronal cells were retained in the column and neurons were collected from the eluted cell fraction. Neuron and Astrocyte Heterochronic Co‐Culture Neurons were obtained as explained before and, after negative magnetic isolation, were plated on 24‐well poly‐l‐lysine and laminin‐coated dishes (100,000 neurons/well). Cells were maintained in MACS Neuro Medium (Miltenyi, 130‐093‐570) supplemented with L‐glutamine (0.5 mM), 2% v/v Neuro Brew‐21 (Miltenyi, 130‐093‐566), and 1% penicillin/streptomycin (P/S). On the first day post‐plating, araC (2 μM) was added to reduce non‐neuronal contamination. The following day, a media change was performed to remove araC. On the third day post‐seeding, astrocytes isolated from the adult hippocampus (2 and 18 months‐old mice) were plated on top of neurons (100.000 ACSA‐2+/well). Cell culture was maintained by replacing 50% of the medium every 4 days. After 8 days of co‐culture, cells were fixed with 4% PFA during 10 min. Immunostaining Immunohistochemistry and immunocytochemistry were performed using standard procedures. Animals were anesthetized with pentobarbital (80 mg/kg) and perfused with PB 0.1 M and 4% PFA followed by 16 h postfixation in 4% PFA at 4°C. The brains were coronally sectioned in a vibratome (Leica Microsystems VT‐1200‐S). The resulting 40 μm free floating sections were collected sequentially generating antero‐posterior reconstructions of the hippocampus conformed by 1 section every 320 μm of hippocampal structure. Stereology was performed by the analysis of at least 3 coronal sections, 40 μm each, separated 320 μm from one another. Sampling started at the first appearance of the infrapyramidal blade of the dentate gyrus. Samples (tissue and cells) were incubated with blocking solution (10% Fetal Bovine Serum in 0.1 M phosphate buffer with or without 0.5% Triton X‐100 depending on the cellular location of the epitope of interest). Primary antibodies used for the staining were as follows: ATP1B2 (1:300, Alomone Labs, ANP‐012), GLAST (ACSA‐1) biotin (1:50, Miltenyi, 130‐119‐161), S100β (1:250, Synaptic Systems, 287004), GFAP (1:1000, Synaptic Systems, 173004), VGLUT1 (1:500, GeneTex, GTX133148), PSD95 (1:200, Fisher, MA1045), Anti‐Pan‐gamma‐protocadherin (10 μg, NeuroMab, clone N159/5), Anti‐gamma‐protocadherin‐C3 (10 μg, NeuroMab, clone N174B/27), TOMM20 (1:100, Abcam, HPA011562) and NDUFA5 (1:50, Proteintech, 16640‐1‐AP). Then, samples were washed with PB and incubated with secondary antibodies at room temperature for 1 or 2 h (cells and tissue, respectively). Secondary antibodies were Cy3 donkey anti‐rabbit (1:500, Jackson, 711‐165‐152), Alexa Fluor 488 donkey anti‐guinea pig (1:500, Jackson, 706‐545‐148), Alexa Fluor 647 donkey anti‐guinea pig (1:500, Jackson, 706‐605‐148), Alexa Fluor 555 donkey anti‐mouse (1:500, Invitrogen, A31570), Alexa Fluor 647 donkey anti‐rabbit (1:500, Invitrogen, A31573) and streptavidin‐Cy2 (green) (1:200, Jackson, 016‐220‐084). Nuclei were counterstained with DAPI 10 μg/mL (Sigma‐Aldrich, D9542). After staining, cells and all sections were mounted and preserved with 50% Mowiol (Polysciences, 17951), 2.5% DABCO (Sigma, D2522). Images were acquired with a Leica Spectral SP8 confocal microscope with 40 or 63× oil objectives. Images were analyzed with Fiji Image J Software (1.53q). Synapse Quantification Excitatory synapses were visualized with presynaptic marker VGLUT1 and with postsynaptic marker PSD95. VGLUT1 and PSD95 signals were only detected in neuronal cultures or in neuronal and astrocyte co‐cultures. No background signal was detected in pure astrocyte cultures (without neurons), confirming the specificity of the VGLUT1 and PSD95 immunostaining (Figure ). The Puncta Analyzer Plugin for ImageJ (Ippolito and Eroglu ) was used to count the number of co‐localized synaptic puncta. This quantification method is based on the fact that pre‐ and post‐synaptic proteins are not within the same cellular compartments and would appear co‐localized only at synapses due to their close proximity. We took images with a Leica SP8 confocal laser‐scanning microscope at ×63 to image synapses. In the co‐cultures employed for synapse quantification (combining MACS‐isolated neurons and astrocytes), DAPI+ nuclei either corresponded to GFAP+ astrocytes or to MAP2+ neurons (Figure ; average ± SEM % cells in the co‐cultures: 38.2% ± 7.8% GFAP+ astrocytes and 61.8% ± 7.8% MAP2+ neurons). MAP2 and GFAP signals were mutually exclusive. In the GFAP/VGLUT1/PSD95 and MAP2/VGLUT1/PSD95 triple immunostainings, the density of DAPI+/GFAP− cells per field was similar to the density of DAPI+/MAP2+ cells (Figure ). Thus, DAPI+/GFAP− cells were considered as putative neurons in further analysis. We quantified synapses following two complementary approaches. First, we quantified pre‐ and post‐synaptic co‐localized puncta in 5 different areas of the co‐culture preparation (15 putative neurons (DAPI+/GFAP− cells) per culture and experimental condition). We reported the final data as the average number of synapses per putative neuron (DAPI+/GFAP−). Additionally, we quantified pre‐ and post‐synaptic co‐localized puncta directly over or in close proximity to GFAP+ astrocytic surfaces by selecting the astrocytic area surrounding the GFAP+ signal as the region of interest (ROI) using the Puncta Analyzer Plugin (ImageJ). Astrocytic ROIs covered 6.5 μm distances to the GFAP+ cytoskeletal signal. We reported the final data as the average number of synapses per GFAP+ cell. RNAscope Fluorescence In Situ Hybridization RNAscope (Advanced Cell Diagnostics, ACD) was performed as follows. Briefly, brains were quickly frozen in Optimum Cutting Temperature compound (Tissue‐Tek), using liquid nitrogen. Fifteen‐micrometer thick brain slices were prepared using a NX70 cryostat (Thermo Fisher Scientific). Sections were subsequently fixed in ice‐cold 4% paraformaldehyde for 30 min. Sections were then dehydrated using a series of ethanol solutions (50%–100%), before drying and incubating with Protease IV for 20 min at room temperature. Slides were washed in phosphate‐buffered saline and hybridized with gene‐specific probes (Table ) for 2 h at 40°C in a HybEZ Oven (ACD). Non‐annealed probes were removed by washing sections in 1× proprietary wash buffer. Probes were then detected via sequential hybridization of proprietary amplifiers and labeled “secondary” probes (Amp 1–Amp 4). Finally, sections were stained with 4′,6‐diamidino‐2‐phenylindole (DAPI) and mounted using ProLong Diamond Antifade Mountant (Life Technologies). Images were acquired with a Leica Spectral SP8 confocal microscope with 40× objective. RNAscope fluorescent images were analyzed using QuPath (version 0.5.1). Whole‐slide images were imported into QuPath, and regions of interest (ROIs) encompassing the hippocampus were manually annotated based on anatomical landmarks. Cell segmentation was performed using QuPath based on DAPI nuclear detection. RNAscope puncta were identified using the Subcellular Detection plugin with identical detection parameters applied to all images. Detection thresholds were optimized using negative control sections to minimize background signal and were subsequently maintained constant throughout the analysis. The number of RNAscope puncta associated with each segmented cell was automatically quantified. Statistics All statistical tests and sample sizes are included in the figure legends. Normality was measured with Shapiro Wilks test. Normal data are shown as mean ± SEM and non‐normal data are represented as median ± interquartile range. In all cases, p values are represented as follows: ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05. For normal data, all quantifications were statistically analyzed using either one sample t‐test (normalized data 2 groups), Student's t‐test‐2 tails (2 groups) or 2 way‐ANOVA tests. For non‐normal data, Mann Whitney or Kruskal–Wallis test was employed. Statistical analysis was performed using Graphpad Prism 8. No statistical methods were used to pre‐determine sample sizes. Results ATP1B2 and GLAST Identify Two Astrocyte Subpopulations in the Adult Mouse Hippocampus That Are Preserved During Aging To investigate astrocyte diversity in the adult hippocampus during lifespan, we quantified the number of ATP1B2+ single‐positive and ATP1B2+/GLAST+ double‐positive cells among the S100β+ astrocytes in young (Y, 2 months) and old (O, 18 months) wild‐type mice by immunofluorescence and confocal microscopy (Figure ). We first calculated the percentage of ATP1B2+ (A+) and ATP1B2+/GLAST+(A+/G+) S100β+ cells in the hippocampus as a whole at both ages. The A+/G+ astrocyte fraction was higher than the A+ fraction in young and old mice (average ± SEM, Y‐A+/G+: 82.6% ± 4.9% and O‐A+/G+: 84.0 ± 6.7 vs. Y‐A+: 17.4% ± 4.9% and O‐A+: 16.0% ± 6.7%) (Figure ). We then analyzed astrocyte heterogeneity across the main non‐neuronal layers of the hippocampal subfields Cornu Ammonis area 1 (CA1) and dentate gyrus (DG), including stratum oriens (SO), stratum radiatum (SR), stratum lacunosum moleculare (SLM), molecular layer (ML), and hilus (Figure ). Again, the majority of astrocytes were A+/G+, with similar proportions across layers. There were no significant differences with aging (Figure ). To confirm astrocyte diversity at the mRNA level, we performed high‐resolution analysis of ATP1B2 and GLAST expression by in situ hybridization (RNAscope), using fluorescent probes for Atp1b2 and Slc1a3 (coding for GLAST) (Figure ). We quantified mRNA at the single‐cell level in the whole hippocampus of young and old mice, excluding the densely packed neuronal layers. Again, the majority of Atp1b2 + astrocytes expressed both astrocyte marker genes regardless of age (average ± SEM, Slc1a3 + /Atp1b2 + cells in Y: 72.6% ± 6.8% and O: 60.7% ± 6.8%, respectively). About one‐third of the Atp1b2 + cells expressed only Atp1b2 + (Y: 27.4% ± 6.8% and O: 39.3% ± 6.8%) (Figure ). We then took a closer look at the different CA1 and DG layers. Cells that co‐expressed both marker genes were the most abundant astrocyte type in all subregions at all ages, although a trend towards a decrease in the fraction of Slc1a3 + /Atp1b2 + double‐positive cells and an increase in Atp1b2 + single‐positive cells was observed with age. Differences were significant in the hilus and SO layers (Figure ). To explore whether changes could reflect a reduction in Slc1a3 expression in the aged astrocytes, we quantified the number of puncta per cell (dots representing mRNA transcripts) as a proxy for the level of single‐cell gene expression. There was an overall decrease in the number of Slc1a3 + puncta (and also Atp1b2 + puncta) per Atp1b2‐expressing cell during aging, while expression of control housekeeping genes like Ubc (coding for Ubiquitin) did not change with age (Figure ). We further confirmed the significant reduction in the number of puncta among the 25 top Atp1b2‐expressing cells. The age‐related decline seemed specific to the hippocampal layers, as no reduction was detected in the cortex (Figure ). Hence, on the basis of ATP1B2 and GLAST mRNA and protein expression, our data confirm the existence of two subpopulations of astrocytes in the hippocampus of young and aged animals. The two subpopulations are distributed throughout all hippocampal layers, most of them being ATP1B2 and GLAST double‐positive astrocytes. A moderate increase in Atp1b2 + single‐positive cells is observed in certain hippocampal layers in old animals. FACS‐Isolation and Bulk RNA Sequencing Reveals Transcriptional Heterogeneity Among Hippocampal Astrocyte Subpopulations We next took advantage of the cell surface expression of ATP1B2 and GLAST proteins to isolate the identified astrocyte subsets. We employed anti‐astrocyte cell surface antigen ACSA‐2 and ACSA‐1 antibodies that recognize ATP1B2 and GLAST epitopes respectively, conjugated to the fluorophores fluorescein isothiocyanate (FITC) and phycoerythrin (PE) (Batiuk et al. ; Borggrewe et al. ; Kantzer et al. ) (Figure and Figure ). Hippocampal astrocyte diversity was confirmed by FACS, with very similar A+ and A+/G+ cell proportions to those detected by immunohistochemistry and RNAscope. The majority of astrocytes from both young and old hippocampus were A+/G+ (average ± SEM, Y: 84.9% ± 4.7% and O: 76.6% ± 8.0%) compared to A+ astrocytes (Y: 15.1% ± 4.7% and O: 23.4% ± 8.0%) (Figure ). Instead, A+ and A+/G+ proportions in forebrain tissue were close to 50% (Y‐A+: 49.9% ± 1.2% and Y‐A+/G+: 50.1% ± 1.2%) (Figure ), in line with published data (Borggrewe et al. ). Differences between hippocampal and forebrain astrocyte proportions were significant, pointing to an enrichment in A+/G+ cells in the hippocampus compared to other brain areas. We next used FACS‐sorting to isolate the hippocampal astrocyte subpopulations from young and old wild‐type mice (Figure ) and performed bulk RNAseq analysis of the sorted cells. Expression of bona fide astrocyte marker genes (Slc1a2, Slc1a3, Atp1b2, Sox9, Aqp4) was high in both A+ and A+/G+ cells, while expression of oligodendrocyte (Olig2, Mog), neuron (Map2, Rbfox3), neural stem cell (NSC; Sox2, Notch1), radial glia cell (RG; Vim, Pax6, Hes1), and ependymal cell (Nfix, Cd24a) genes was low, as shown in Figure heatmap. Expression of microglia (Cx3cr1, Cd11b, Iba1), endothelial cell (Pecam1, Cd34, Flt1), and additional NSC/progenitor genes (Nes) was not detected. These results indicate that the isolated cells were highly enriched in astrocytes and not significantly contaminated by these other cell types. To further confirm the identity of the isolated cells, we next compared the top 500 expressed genes of A+ and A+/G+ populations (Tables and ) with other published astrocyte signatures (de Ceglia et al. ; Borggrewe et al. ; Batiuk et al. ). About 296 of the top expressed genes (59%) were common for A+ and A+/G+ populations, and high overlap was found with other datasets (Figure ). We also analyzed the mean expression of genes involved in typical astrocyte functions such as: cholesterol metabolism, blood brain barrier (BBB), myelination and lactate metabolism (Borggrewe et al. ) (Figure and Table ). Genes involved in the four categories were more expressed in A+/G+ than in A+ astrocytes regardless of age. In addition, we interrogated our bulk RNAseq dataset for the Batiuk et al. classification of five astrocyte subtypes, previously identified by sc‐RNAseq in the adult mouse hippocampus and cortex (AST1‐5; Table ) (Batiuk et al. ). Genes of the mature hippocampal subtypes “AST1‐3” were found mostly expressed in O‐A+/G+ astrocytes, whereas A+ astrocytes expressed intermediate levels of “AST1‐3” signature genes and low levels of “AST2” cortical signature genes. Progenitor cell subtype “AST4” genes were equally shared among the A+ and A+/G+ astrocytes, and intermediate progenitor astrocyte subtype “AST5” genes were found slightly more expressed in A+/G+ astrocytes. Finally, we compared our dataset to the astrocyte gene expression profiles recently described for 13 mouse central nervous system (CNS) regions (Endo et al. ). Out of the 825 astrocyte‐enriched genes shared across these different regions, 757 core genes (92%) were expressed in our dataset. All four astrocyte populations from our study showed positive enrichment of this core astrocytic signature, consistent with an astrocyte‐like transcriptional program (Figure ). Enrichment was highest in O‐A+/G+ and lowest in Y‐A+. We then focused on the top 50 genes conserved in astrocytes across the CNS. The vast majority of these core genes (94%, 47 genes) were shared in hippocampal A+ and A+/G+ astrocytes (Figure ). Genes belonging to the top astrocyte‐enriched pathways identified by Endo et al. , related to K+ homeostasis (Atp1a2, Atp1b2, Kcnj10), neurotransmitter homeostasis (Aldh1l1, Slc1a2, Slc6a11, Slc1a3, Slac38a3, Slc25a18), cholesterol metabolism (Acot11, Acsbg1, Apoe, Clu, Fads2) and glucose metabolism (Aldoc, Pygm) are highlighted in Figure . We next focused on the differentially expressed genes (DEGs) that distinguished the A+ and A+/G+ astrocyte transcriptome. Bulk RNAseq analysis showed 548 DEGs (p adj. < 0.05) when comparing the two astrocyte subpopulations in young animals (Figure and Table ). About 469 DEGs were overexpressed in Y‐A+/G+ astrocytes and 79 in Y‐A+ astrocytes, as shown in the Volcano plot (Figure ). Functional enrichment of the differentially up‐regulated genes in Y‐A+/G+ and Y‐A+ astrocytes is shown in Figure (GO Biological Process). Y‐A+/G+ astrocyte transcriptome was significantly enriched in genes related to protein glycosylation and assembly of late multivesicular endosomes, two processes involved in membrane protein dynamics and secretion (Figure and Table ). Glycosylation at the ER and Golgi modifies proteins directed to the cell membrane or secreted to the extracellular space. Protein glycosylation up‐regulated genes in Y‐A+/G+ astrocytes encoded, among other enzymes, mannosyltransferases (Alg1, Alg3), glucosyltransferases (Alg6), N‐glycan branching enzymes (Mgat2 and Mgat4 isoforms) and sialyltransferases that add sialic acid to N‐glycans (St8sia5). To confirm that overexpression of the enzymes indeed resulted in elevated glycosylation of cell surface proteins, we took advantage of the fluorescein‐conjugated leukocyte‐phytohemagglutinin (L‐PHA), a plant lectin highly specific for branched N‐glycans (Yale et al. ). Lectin flow cytometry with L‐PHA combined with ACSA‐2 and ACSA‐1 detected a significant raise in L‐PHA binding in Y‐A+/G+ astrocytes compared to Y‐A+ astrocytes, reflecting an increased level of N‐glycosylation in the ATP1B2 and GLAST double‐positive astrocyte population (Figure ). Multivesicular body assembly and late endosome to vacuole transport categories enriched in Y‐A+/G+ astrocytes included charged multivesicular body protein genes Chmp7 and Chmp2b and several vacuolar protein sorting (VPS) genes. Other genes coding for WASH complex proteins, involved in regulating endosomal protein sorting, such as Washc3 and Washc5 were also overexpressed in Y‐A+/G+ astrocytes (Figure ). Expression of Rab family of small GTPases genes (Rab9, Rab11a) controlling intracellular vesicular transport and receptor recycling back to the plasma membrane was increased as well. Macroautophagy/Lysosomal‐related genes implicated in the turnover of cytoplasmic components, such as Atg4c, were upregulated in Y‐A+/G+ astrocytes. Interestingly, Y‐A+/G+ astrocytes were also enriched in mitochondrial transport genes and greatly overexpressed cytochrome c oxidase mitochondrial respiratory complex IV assembly factor gene Coa6 (Figure ). Coa6 was the coding gene with highest normalized fold change in expression in Y‐A+/G+ compared to Y‐A+, pointing to differences in mitochondrial activity between the two astrocyte subpopulations. In addition, Y‐A+/G+ astrocytes showed increased expression of a subset of cholesterol‐related genes compared to Y‐A+ astrocytes (Figure ), including Sc5d and Mvd that encode sterol‐C5‐desaturase and mevalonate diphosphatase decarboxylase, respectively, two crucial enzymes in cholesterol biosynthesis. We quantified Mvd expression per cell by RNAscope technique in two hippocampal layers containing abundant astrocytes, the hilus and molecular layer (ML). In both layers, the number of Mvd puncta per cell was higher in Slc1a3 + /Atp1b2 + cells than in Atp1b2 + cells (Figure ). These results confirm the increase in Mvd mRNA in ATP1B2 and GLAST double‐positive astrocytes compared to ATP1B2 single‐positive astrocytes. Regarding the transcriptomic signature of ATP1B2 single‐positive astrocytes, as mentioned above only 79 genes were overexpressed in Y‐A+ cells compared to Y‐A+/G+ (Figure and Table ). Functional enrichment (GO Biological Process) of the Y‐A+ upregulated genes highlighted functions such as negative regulation of muscle cell differentiation and imprinting (Igf2), mRNA splicing (e.g., Scnm1, Celf4) and regulation of microtubule assembly in mitosis and spindle checkpoint signaling (e.g., Drg1, Hspa1a). The DNA polymerase gene Pola1 implicated in DNA replication and cell division, and the cyclin‐dependent kinase regulators Ccnt1 and Cdk5rap1 were also overexpressed in Y‐A+ cells. In summary, GLAST allows to distinguish two ATP1B2‐expressing astrocyte subpopulations in the adult hippocampus, A+ and A+/G+, that are transcriptionally distinct. Their gene expression profile is shared in part with astrocyte subtypes identified in previous studies. Functional enrichment analysis of the transcriptomic signatures and validation studies suggest that ATP1B2/GLAST double‐positive astrocytes correspond to glial cells with increased protein glycosylation and specialized functions. Age‐Related Transcriptional Changes Differ Between Hippocampal Astrocyte Subpopulations We next analyzed the transcriptomic changes of the FACS sorted hippocampal astrocytes in old compared to young animals. Interestingly, while the A+ astrocyte transcriptome profoundly changed during aging (1935 DEGs in O‐A+ vs. Y‐A+, Figure and Table ), the A+/G+ astrocyte transcriptome remained quite stable (only 67 DEGs in O‐A+/G+ vs. Y‐A+/G+, Figure and Table ). For both astrocyte populations, most DEGs corresponded to down‐regulated genes (70% in O‐A+ and 88% in O‐A+/G+). Common down‐regulated targets during aging included the ubiquitination and proteasomal degradation‐related gene Skp2, the metalloproteinase Adamts20 involved in tissue‐remodeling and cilium‐related genes. One shared gene (Ctu2) involved in translation fidelity was up‐regulated both in O‐A+/G+ and O‐A+ cells compared to their young counterparts (Figure ). Biological functions enriched in the down‐regulated A+/G+ gene list during aging were related to plasma membrane cell projection organization and neuron development, amino acid metabolism and protein secretion (Figure ). Further inspection of the list uncovered several members of the cell adhesion γ‐protocadherin (Pcdhg) gene cluster, ciliary neurotrophic factor (Cntf) and ceruloplasmin (Cp) (Figure and Table ). Functional enrichment was not followed up in up‐regulated O‐A+/G+ targets due to the limited number of DEGs (only 8, including the complement gene C1qa, lncRNA Gm39468 and the lysosomal‐associated protein coding gene Laptm5). Transcriptome stability of the most abundant double‐positive astrocyte population was supported by the comparative analysis of astrocyte gene expression profiles between 20‐month and 5‐month old hippocampal astrocyte samples using publicly available single‐cell RNAseq data (Habib et al. ). Pseudo‐bulk representation of the RNAseq data for each condition and correlation calculation across all genes indicated strong overall similarity (0.93 Spearman rank correlation coefficient), suggesting relative stability of the hippocampal astrocytic gene expression program across age, with limited global transcriptomic divergence. Regarding the differentially expressed genes in A+ astrocytes during aging, functional enrichment of the down‐regulated targets identified processes such as: protein folding (several DnaJ heat shock protein (HSP) genes and representative members of the stress‐inducible HSP70 family genes), protein modification, vacuolar transport, mRNA Processing/Splicing (including Celf4 and Scnm1 overexpressed in Y‐A+ compared to Y‐A+/G+) and cell surface receptor Serine/Threonine kinase signaling (Figure ). Other repressed genes were linked to protein trafficking from the ER to the Golgi (Gorab), genome stability (RNA helicase Ddx21), cell cycle progression/proliferation modulators (e.g., Ppp2cb, Cdc40, Jumjd6) and cytokine production (Ilrun) (Figure ). As for the up‐regulated genes in A+ astrocytes during aging, many were involved in mitochondrial electron transport‐mediated ATP synthesis (e.g., Cox5a, Coa6, Uqcr10, Ndufa10, Ndufc2) and cholesterol biosynthesis (e.g., Mvd, Hmgcs1, Dhcr24) (Figure ). To confirm the increase in electron transport chain components, we isolated A+ astrocytes from the hippocampus of young and old mice by FACS. Single‐positive astrocytes were then adhered onto coated coverslips and immunofluorescence analysis was performed shortly after. As shown in Figure , Complex I subunit (NDUFA5) intensity normalized to total mitochondrial content per cell (measured with TOMM20) was increased in old A+ astrocytes (Figure ). Interestingly, TOMM20 signal was decreased in O‐A+ compared to Y‐A+ astrocytes, pointing to an increase in electron transport components despite an overall reduction in mitochondria. Other biological functions uncovered in O‐A+ astrocytes include chromatin‐related processes (up‐regulation of transcriptional co‐activators, SAGA‐complex and DNA repair related proteins) and Wnt signaling pathway genes (e.g., Kremen1, Celsr2) (Figure ). Thus, hippocampal A+ astrocytes in old mice down‐regulate genes linked to cellular processes that distinguish them from A+/G+ astrocytes in young mice (i.e., splicing) and rewire their metabolism, increasing the expression of genes involved in mitochondrial ATP synthesis and cholesterol biosynthesis. In addition, some of the up‐regulated targets in the single‐positive A+ astrocytes during aging were protein glycosylation genes overexpressed in Y‐A+/G+ (St8sia5, Figure ), altogether pointing to a plastic cellular response and to the acquisition of a more specialized state. ATP1B2 and GLAST Double‐Positive Astrocytes Repress γ‐Protocadherin Genes During Aging and Fail to Support Excitatory Synapse Formation Since ATP1B2 and GLAST double‐positive astrocytes predominate in the hippocampus (80% of the astrocytes, Figures and ), we next explored the O‐A+/G+ RNAseq dataset for DEGs that could account for the age‐related decline in astrocyte physiological functions. We focused on the loss of synaptogenic function previously suggested for old (Boisvert et al. ) and senescent astrocytes (Matias et al. ; Ercoli et al. ). Astrocytes promote excitatory synapse formation by secreting synaptogenic proteins and also through physical cell‐to‐cell contacts with neurons. Protocadherin proteins localize to perisynaptic astrocyte processes and have been reported to facilitate synaptogenesis (Garrett and Weiner ). As shown in Figure , the RNAseq analysis identified four γ‐protocadherin coding genes significantly down‐regulated during aging in O‐A+/G+ astrocytes (but not in O‐A+ astrocytes, Figure ). Inspection of available transcriptomic datasets (Zhang et al. ; Zhang et al. ) indicated that three of these Pcdhg genes are expressed at equal levels in neurons and astrocytes, while expression of Pcdhgc3 encoding γ‐C3 protocadherin is highly enriched in astrocytes (Figure ) (Lee et al. ). To confirm γ‐C3 protein expression in hippocampal A+/G+ astrocytes and γ‐C3 reduction during aging, double‐positive astrocytes were isolated from the hippocampus of young and old mice by FACS using ACSA‐1/ACSA‐2 and by magnetic‐activated cell sorting (MACS) using ACSA‐2. FACS‐isolated A+/G+ astrocytes were adhered onto coated coverslips and immunofluorescence analysis was performed. As shown in Figure , γ‐C3 protein levels were reduced in acutely isolated O‐A+/G+ astrocytes. Besides, MACS‐isolated astrocytes were cultured in vitro in defined medium without serum, a procedure that maintains the in vivo astrocyte properties while avoiding the induction of a reactive astrocyte signature (Figure ) (Caldwell et al. ). The vast majority of the S100β+ astrocytes expressed both ATP1B2 and GLAST proteins (92.9% ± 3.9% A+/G+) (Figure ). Thus, we considered these primary cultures as highly enriched in hippocampal A+/G+ astrocytes. We were unable to establish A+/G− primary astrocyte cultures via MACS as a control due to technical limitations. Quantitative immunofluorescence analysis demonstrated γ‐C3 protein expression in Y‐A+/G+ cultures and decreased γ‐C3 signal intensity in O‐A+/G+ cultures (Figure ). γ‐C3 signal was poorly detected in MACS‐isolated primary hippocampal neurons (MAP2+cells, Figure ). However, pan‐γ‐protocadherin signal was detected in both neurons and astrocytes (Figure ). This confirmed the presence γ‐protocadherins in the astrocytic and neuronal compartments, the predominant γ‐C3 expression in young astrocytes and its reduction in old astrocytes. Astrocyte‐neuron γ‐protocadherin contacts are necessary for proper neuronal synapse formation and stabilization (Garrett and Weiner ; LaMassa et al. ), so we reasoned that γ‐protocadherin reduction in aged astrocytes could affect synaptogenesis. We designed a functional heterochronic in vitro assay to compare the synaptogenic capacity of young and old hippocampal astrocytes (Figure ). The co‐culture system allowed for direct neuron‐astrocyte contacts between young (2 m) or old (18 m) primary hippocampal astrocytes and young hippocampal neurons (E18). We assessed excitatory synapse formation in the heterochronic system through immunofluorescence and co‐localization image analysis of the pre‐synaptic vesicle marker VGLUT1 (Vesicular Glutamate Transporter 1) and the post‐synaptic marker PSD95 (Post‐Synaptic Density protein 95) (Ippolito and Eroglu ). Excitatory synapses were reduced by 50% in old astrocyte co‐cultures compared to young ones, both when quantified as co‐localized puncta directly over the GFAP+ astrocytic surfaces (Figure ) or when quantified as co‐localized puncta normalized to GFAP− cells (corresponding to MAP2+ co‐cultured neurons), to take into account possible minor fluctuations in hippocampal neuronal density (Figure ). γ‐protocadherin puncta localized to many sites adjacent to pre‐synaptic VGLUT1 puncta, in line with published studies (Garrett and Weiner ; LaMassa et al. ; not shown). Thus, O‐A+/G+ hippocampal astrocytes fail to support excitatory synaptogenesis in hippocampal neuronal cultures, a dysfunction that correlates with the age‐related decrease in cell adhesion molecules of the γ‐protocadherin protein family, including γ‐C3. Discussion Astrocyte diversity in the mammalian brain is an active research area that is challenging the long‐held conception of astrocytes as a homogeneous cell population (Boisvert et al. ; Morel et al. ; Bayraktar et al. ; Batiuk et al. ; Borggrewe et al. ; Kantzer et al. ; Karpf et al. ; de Ceglia et al. ; Viana et al. ; Zhou et al. ). Astrocytes perform many essential functions in brain homeostasis, but it is currently unclear whether different astrocytes from the brain's collection perform similarly all tasks (Hennes et al. ). As a complementary approach for studying astrocyte diversity in the hippocampus throughout aging, in this study we have taken advantage of the cell surface proteins GLAST and ATP1B2, since combined and single expression of these markers has previously allowed for the prospective isolation and transcriptomic analysis of astrocyte subpopulations from other brain regions. In line with findings in forebrain, spinal cord, hindbrain and cerebellum (Borggrewe et al. ; Kantzer et al. ), here we demonstrate that GLAST and ATP1B2 expression discriminates between two astrocyte subsets in the hippocampus: the double‐positive ATP1B2+/GLAST+ and the single‐positive ATP1B2+ astrocytes, with non‐detectable GLAST levels. While previous FACS analysis indicated that ATP1B2+/GLAST+ astrocyte proportions ranged from 40% to 60% in forebrain, to 20% in hindbrain or 1% in spinal cord (Borggrewe et al. ), we found that the frequency of the double‐positive cells in the hippocampus was strikingly high (> 80%) across all layers, in young and old mice, highlighting the regional heterogeneity of GLAST expression. A recent study explored to a limited extent GLAST and ATP1B2 expression in the hippocampal dentate gyrus of young mice (Karpf et al. ). ATP1B2 was found to be highly present in hilus astrocytes compared to granular zone or molecular layer astrocytes. In our study, ATP1B2+ enrichment was only detected in hilus astrocytes when analyzed at the mRNA level in 18‐month old mice. The relative increase in Atp1b2 + astrocytes in certain layers, such as the hilus, in aged animals raises the possibility that some Atp1b2 single‐positive astrocytes arise from downregulation of Slc1a3/GLAST in previously double‐positive cells. Thus, rather than representing a fixed cellular state, it is possible that both subpopulations are related to each other. Besides, reduced Slc1a3/GLAST expression was detected only at the mRNA level, and the shift in the proportion of double‐positive cells was significant only in some layers (Figure ). This layer‐specific change suggests an increased susceptibility of the astrocytes from those subregions to aging‐related changes. Nevertheless, it is important to note that immunofluorescence analysis showed no significant differences in percentage of ATP1B2+ and ATP1B2+/GLAST+ cells classified on the basis of GLAST protein expression (Figure ). Similarly, although reduced Slc1a3/GLAST mRNA expression could potentially influence FACS classification, in line with the immunofluorescence analysis, FACS data showed no differences in the overall proportion of ACSA‐1+/ACSA‐2+ (GLAST+/ATP1B2+) and ACSA‐2+ (ATP1B2+) astrocytes (Figure ), minimizing the impact of Slc1a3/GLAST mRNA downregulation on FACS sorting (and subsequent RNAseq comparisons) of old samples compared to young ones. Collectively, our data employing three independent techniques (immunofluorescence, RNAscope and FACS) reveal that ATP1B2+/GLAST+ astrocytes are plentiful across the hippocampus, sharing territories with a less abundant subset of astroglial cells classified as ATP1B2+ astrocytes. We found substantial differences in the gene expression profiles of ATP1B2+/GLAST+ and ATP1B2+ hippocampal astrocytes by bulk RNAseq. Two studies (Borggrewe et al. ; Kantzer et al. ) previously compared the transcriptome of single‐ and double‐positive astrocytes in other regions. Borggrewe et al. failed to detect DEGs when comparing GLAST+ versus GLAST− forebrain astrocytes. In the hindbrain, the GLAST− astrocyte transcriptome was enriched in glial cell differentiation and myelination genes. Overall mean expression of genes involved in cholesterol metabolism and blood–brain barrier was higher in GLAST+ compared to GLAST− astrocytes, while lactate metabolism genes were more expressed in GLAST− astrocytes (Borggrewe et al. ). Moreover, the “AST5” astrocyte intermediate progenitor signature (Batiuk et al. ) was more associated with hindbrain and forebrain GLAST− astrocytes. Expanding these observations, in our dataset the transcriptomic signature of hippocampal GLAST− astrocytes (ATP1B2+ only) did not clearly overlap with the “AST5” gene expression profile. Progenitor cell subtype “AST4” gene signature was equally shared among the single‐ and double‐positive astrocytes and predominated in young animals compared to old ones. As discussed below, functional enrichment analysis of the transcriptomic data and validation assays suggest that ATP1B2+/GLAST+ double‐positive hippocampal astrocytes represent a more specialized cellular state compared to ATP1B2+ astrocytes. Mature astrocytes are highly secretory cells with a finely regulated exocytotic system (Verkhratsky et al. ). They communicate with neighboring cells, including neurons, through the release of neuroactive compounds, neurotransmitters, signaling molecules, and through cell adhesion proteins and cell‐to‐cell contacts as well. Interestingly, hippocampal ATP1B2+/GLAST+ double‐positive astrocytes expressed higher levels of protein glycosylation genes, particularly N‐linked glycosylation, and were highly stained for L‐PHA, a specific lectin for branched N‐glycans. The addition of sugar molecules is a very common modification for secreted and membrane‐bound proteins. Thus, the increased glycosylation detected in ATP1B2+/GLAST+ double‐positive astrocytes reinforces their view as functionally specialized cells, actively involved in interactions with other brain cell types. Compared to ATP1B2+ single‐positive astrocytes, the double‐positive ones also overexpressed genes involved in vesicular transport, cholesterol synthesis, and metabolism, a set of functions that characterize mature astrocytes (Pfrieger and Ungerer ; Verkhratsky et al. ). Conversely, ATP1B2+ astrocytes differentially overexpressed a limited number of genes when compared to ATP1B2+/GLAST+ astrocytes. These genes were involved in DNA replication, RNA processing, and cell division. Thus, the transcriptomic data tentatively suggest that, compared to double‐positive astrocytes, ATP1B2+ astrocytes are perhaps more susceptible to undergo reactivation in response to extrinsic signals, a hypothesis that remains to be tested. We also found remarkable differences in the transcriptomic response of the two hippocampal astrocyte subpopulations during aging. The ATP1B2+ transcriptome was very plastic and vast changes in gene expression were detected in 18‐month‐old compared to 2‐month‐old animals. This cell response was defined by the up‐regulation of a battery of genes involved in mitochondrial respiration and metabolic rewiring. The shift highlights the capacity of the ATP1B2+ cells to respond to the aged brain environment. In contrast, the RNAseq data indicate that double‐positive astrocytes withstand aging without undergoing dramatic transcriptomic changes, thereby maintaining relatively stable levels of gene expression. Currently, we do not know whether different epigenetic states underlie the plastic versus stable gene expression pattern identified in the two astrocyte subpopulations during aging. It is important to note that the bulk RNAseq methodology employed in this study yields an averaged gene expression profile across all cells in a sample. This approach can mask additional cellular heterogeneity within the FACS‐isolated subpopulations. In this regard, the few DEGs in the Y‐A+/G+ vs. O‐A+/G+ comparison can reflect transcriptome stability of the double‐positive astrocytes during aging or can result from averaging transcriptomic changes of currently undefined heterogeneous cell states within the bulk ATP1B2+/GLAST+ population. To clarify this, further sc‐RNAseq analysis of double‐positive astrocytes during aging will be required. Nevertheless, astrocytes from published hippocampal sc‐RNAseq studies exhibited a highly conserved global transcriptomic profile between old and young animals, suggesting relative stability of the astrocytic gene expression program across age (Habib et al. ; Schneider et al. ). In line with these data, a published sc‐RNAseq analysis of human hippocampal astrocytes from Alzheimer's disease patients shows that only selected astrocyte subpopulations, associated with disease response, exhibit a limited number of DEGs, being mostly downregulated genes (Su et al. ). Interestingly, although ATP1B2+/GLAST+ astrocytes (the most abundant hippocampal subpopulation) undergo little transcriptomic changes in 18‐month‐old mice compared to younger animals, a subset of DEGs (protocadherin genes, complement cascade genes) point to an impaired function of the old hippocampal double‐positive astrocytes in synapse formation and maintenance. During normal aging, the number of synapses decreases from 15% to 50% depending on the species and brain area, compromising neuronal connectivity (Pannese ). In certain hippocampal subregions, aged rodents with learning deficits show reduced synaptic markers (Smith et al. ). Moreover, loss of synaptogenic function has been previously suggested for old (Boisvert et al. ) and senescent astrocytes (Matias et al. ; Ercoli et al. ). Astrocytes from a variety of brain regions other than hippocampus (visual cortex, motor cortex, cerebellum and hypothalamus) showed marked alterations in the expression of several synapse‐regulating genes during aging (Boisvert et al. ). This finding is in line with the poor supportive role of old hippocampal astrocytes in the heterochronic synaptogenesis assays performed in the current study. While complement cascade components involved in synapse elimination were up‐regulated in a coordinated manner in aged astrocytes from all the aforementioned brain areas, the synapse inducing genes Thbs1 and Thbs4 showed region‐specific changes and were significantly decreased in astrocytes from the aging cerebellum and hypothalamus, respectively (Boisvert et al. ; Clarke et al. ). Thbs1 was also downregulated in senescent astrocytes from a mouse model with accelerated pathological aging (Ercoli et al. ). We add the γ‐protocadherin (Pcdhg) gene cluster to this list of synapse regulatory genes altered during aging in astroglial cells. Since the reduced synaptogenic support observed in aged ATP1B2+/GLAST+ astrocytes resembles functional alterations previously associated with astrocyte senescence, future studies should carefully explore if ATP1B2+/GLAST+ astrocytes from the aged hippocampus of wild type mice accumulate senescence‐associated marks. A preliminary examination of our bulk RNAseq dataset failed to detect expression of most classical senescence‐related markers in the astrocytes perhaps due to low transcript levels (not shown). Protocadherins are expressed by both neurons and astrocytes and have relevant roles in developmental synapse formation, maturation and stabilization (Peek et al. ; LaMassa et al. ). γ‐Pcdh proteins establish adhesive homophilic trans‐interactions and promiscuous cis‐interactions with other γ‐Pcdh proteins through their extracellular domains (Peek et al. ). Combinatorial γ‐Pcdh expression in neurons orchestrates dendritic arborization and synaptic connectivity in the neocortex, allowing discrimination between self and non‐self (Molumby et al. ; Zhu et al. ). In astrocytes, γ‐Pcdh proteins localize to perisynaptic astrocyte processes and γ‐Pcdh cell–cell contacts between astrocytes and neurons facilitate synaptogenesis (Garrett and Weiner ). In vivo, hippocampal γ‐Pcdh immunopositive synapses are larger and more mature (LaMassa et al. ) while restricted mutation of the Pcdhg gene cluster in astrocytes delays synapse formation, at least in the spinal cord (Garrett and Weiner ). In our study, decreased γ‐C3 levels in hippocampal astrocytes from old mice correlates with their loss of excitatory synaptogenic capacity, as shown in heterochronic neuron‐astrocyte co‐cultures that allow cell‐to‐cell contacts. Recent data demonstrate γ‐C3 expression by virtually all cortical Slc1a3 + (GLAST+) astrocytes and uncover a cell‐autonomous role of γ‐C3 in astrocyte self‐recognition during astrocyte morphogenesis (Lee et al. ). Interestingly, astrocyte morphology in the cortex and hippocampus of γC3‐KO mice shows reduced territory size and volume (Lee et al. ). Given astrocytes shrink during aging (Popov et al. ), it will be interesting to explore in the future whether γ‐C3 downregulation in ATP1B2+/GLAST+ hippocampal astrocytes from old mice influences astrocyte morphology. The loss of cell adhesion molecules, including protocadherins, may not only affect the interaction of perisynaptic processes between astrocytes and neurons, but may also have other negative consequences on the structural complexity and function of astrocytes in pathological aging (Lee et al. ). Neurodegenerative diseases are characterized simultaneously by increased astrocyte hypertrophy (associated with the reactive phenotype) and astrocyte atrophy (Verkhratsky et al. ). Since impaired astrocyte function can disrupt neuronal circuitry and drive pathogenesis, brain repair could benefit from therapeutic strategies directed towards the astrocytic compartment, such as transplantation of engineered astrocytes, reprogramming of endogenous astrocytes to restore youthful capabilities or recruiting specific astrocyte subsets to fulfill lost functions (Pihlaja et al. ; Giralt et al. ; Proschel et al. ; Lattke and Guillemot ; Chierzi et al. ). A key goal for the future is to leverage molecular diversity data to develop tools that allow targeted manipulation of astrocyte subtypes. In summary, our work identifies two astrocyte subpopulations in the adult mouse hippocampus that are preserved during aging and provides a new resource for understanding the transcriptional differences between ATP1B2+ single‐positive and ATP1B2+/GLAST+ double‐positive astrocytes. We also highlight the contrasting transcriptomic changes observed during aging in these two astrocyte subpopulations, which point to distinct cellular responses and to a specific loss of synaptogenic support of the more abundant and functionally specialized double‐positive astrocytes. How these responses influence the progression of age‐related diseases remains to be elucidated. A deeper understanding of astrocyte heterogeneity will open new avenues for modulating processes related to aging and brain pathology.